TABLE 3.
Antimicrobial resistance patterns among V. vulnificus strains isolated during the oyster relaying process
| Antibiotic | % with profilea: |
||
|---|---|---|---|
| S | I | R | |
| Amikacinb | 88 | 12 | 0 |
| Amoxicillin-clavulanic acid | 66 | 9 | 26 |
| Ampicillin | 72 | 2 | 26 |
| Ampicillin-sulbactam | 93 | 3 | 3 |
| Cefepime | 93 | 5 | 2 |
| Cefotaximeb | 91 | 2 | 7 |
| Cefoxitin | 36 | 47 | 17 |
| Ceftazidimeb | 72 | 16 | 12 |
| Ceftriaxoneb | 78 | 10 | 12 |
| Cephalothin | 31 | 2 | 67 |
| Chloramphenicol | 86 | 12 | 2 |
| Ciprofloxacinb | 100 | 0 | 0 |
| Doxycyclineb | 71 | 9 | 21 |
| Imipenem | 76 | 9 | 16 |
| Levofloxacinb | 100 | 0 | 0 |
| Meropenem | 95 | 5 | 0 |
| Piperacillin | 100 | 0 | 0 |
| Piperacillin-tazobactam | 100 | 0 | 0 |
| Tetracyclineb | 64 | 7 | 29 |
| Trimethoprim-sulfamethoxazoleb | 98 | 0 | 2 |
a
S, susceptible; I, intermediate; R, resistant.
b
CDC-recommended antibiotic for Vibrio infections.